RZLT Rezolute, Inc.
Nasdaq · SEC CIK 1509261 · EDGAR
- Bought, last 12 months
- $289.0K 8 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 99 since 2021-07-14, latest 2026-09-03 16:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Evans Daron | CFO | $161.4K | — |
| Elam Nevan C | CEO, Dir | $50.9K | — |
| ROBERTS BRIAN KENNETH | Chief Medical Off | $47.6K | — |
| Karnawat Sunil Ratilal | Chief Commercial Off | $19.6K | — |
| Hogenhuis Wladimir | Dir | $9,548 | — |
| FAUCHET PHILIPPE | Dir | — | — |
| Harris Erik | Dir | — | — |
| Kim Young-Jin | Dir | — | — |
| KREHER NERISSA | Dir | — | — |
| Labrucherie Gil M | Dir | — | — |
Transactions 83
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 16:42 | 2026-09-02 | RZLT | Karnawat Sunil Ratilal | Chief Commercial Off | F - Tax | $4.50 | -2,267 | 69.3K | -3% | -$10.2K | |
| 2026-07-07 18:36 | 2026-07-02 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | F - Tax | $4.99 | -3,062 | 293.9K | -1% | -$15.3K | |
| 2026-07-07 17:27 | 2026-07-02 | RZLT | Elam Nevan C | CEO, Dir | F - Tax | $4.99 | -8,004 | 605.5K | -1% | -$39.9K | |
| 2026-07-07 17:26 | 2026-07-02 | RZLT | Evans Daron | CFO | F - Tax | $4.99 | -3,062 | 411.4K | -0.7% | -$15.3K | |
| 2026-03-31 | 2026-03-30 | RZLT | Evans Daron | CFO | P - Purchase | $2.85 | +10.0K | 414.5K | +2% | +$28.5K | |
| 2026-03-04 | 2026-03-02 | RZLT | Evans Daron | CFO | F - Tax | $2.99 | -11.4K | 404.5K | -3% | -$34.2K | |
| 2026-03-04 | 2026-03-02 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | F - Tax | $2.99 | -11.4K | 296.9K | -4% | -$34.2K | |
| 2026-03-04 | 2026-03-02 | RZLT | Elam Nevan C | CEO, Dir | F - Tax | $2.99 | -27.6K | 613.5K | -4% | -$82.6K | |
| 2025-12-17 | 2025-12-16 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $1.69 | +5,650 | 119.7K | +5% | +$9,548 | |
| 2025-12-17 | 2025-12-16 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.70 | +28.0K | 308.4K | +10% | +$47.6K | |
| 2025-12-15 | 2025-12-15 | RZLT | Elam Nevan C | CEO, Dir | P - Purchase | $1.59 | +32.0K | 641.1K | +5% | +$50.9K | |
| M | 2025-12-15 | 2025-12-15 | RZLT | Karnawat Sunil Ratilal | Chief Commercial Off | P - Purchase | $1.62 | +12.1K | 71.4K | +20% | +$19.6K |
| 2025-12-15 | 2025-12-15 | RZLT | Evans Daron | CFO | P - Purchase | $1.77 | +40.0K | 415.9K | +11% | +$70.8K | |
| MI | 2025-12-15 | 2025-12-15 | RZLT | Evans Daron | CFO | P - Purchase | $1.79 | +5,000 | 7,000 | +250% | +$8,950 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Harris Erik | Dir | A - Grant | $0.00 | +21.0K | 21.0K | New | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Evans Daron | CFO | A - Grant | $0.00 | +107.0K | 375.9K | +40% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Karnawat Sunil Ratilal | Chief Commercial Off | A - Grant | $0.00 | +32.0K | 59.4K | +117% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | FAUCHET PHILIPPE | Dir | A - Grant | $0.00 | +21.0K | 55.5K | +61% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | A - Grant | $0.00 | +123.0K | 280.4K | +78% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Labrucherie Gil M | Dir | A - Grant | $0.00 | +21.0K | 55.5K | +61% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Elam Nevan C | CEO, Dir | A - Grant | $0.00 | +317.0K | 609.1K | +109% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Hogenhuis Wladimir | Dir | A - Grant | $0.00 | +21.0K | 114.0K | +23% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | KREHER NERISSA | Dir | A - Grant | $0.00 | +21.0K | 58.6K | +56% | $0 |
| D | 2025-11-21 | 2025-11-19 | RZLT | Kim Young-Jin | Dir | A - Grant | $0.00 | +21.0K | 170.9K | +14% | $0 |
| D | 2025-08-27 | 2025-08-18 | RZLT | Karnawat Sunil Ratilal | Chief Commercial Off | A - Grant | $0.00 | +25.0K | 27.4K | +1,024% | $0 |
| 2025-06-26 | 2025-06-25 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $4.38 | +2,500 | 15.5K | +19% | +$10.9K | |
| 2025-06-24 | 2025-06-24 | RZLT | Evans Daron | CFO | P - Purchase | $4.05 | +5,000 | 268.9K | +2% | +$20.2K | |
| 2025-06-23 | 2025-06-13 | RZLT | KREHER NERISSA | Dir | P - Purchase | $3.25 | +3,076 | 37.6K | +9% | +$9,997 | |
| I | 2025-06-23 | 2025-06-13 | RZLT | Kim Young-Jin | Dir | P - Purchase | $3.25 | +1.23M | 8.42M | +17% | +$4.00M |
| D | 2025-06-13 | 2025-06-10 | RZLT | KREHER NERISSA | Dir | A - Grant | $0.00 | +9,000 | 34.5K | +35% | $0 |
| D | 2025-06-13 | 2025-06-10 | RZLT | Labrucherie Gil M | Dir | A - Grant | $0.00 | +9,000 | 34.5K | +35% | $0 |
| D | 2025-06-13 | 2025-06-10 | RZLT | Hogenhuis Wladimir | Dir | A - Grant | $0.00 | +9,000 | 93.0K | +11% | $0 |
| D | 2025-06-12 | 2025-06-10 | RZLT | Kim Young-Jin | Dir | A - Grant | $0.00 | +9,000 | 149.9K | +6% | $0 |
| D | 2025-06-12 | 2025-06-10 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | A - Grant | $0.00 | +26.0K | 157.4K | +20% | $0 |
| D | 2025-06-12 | 2025-06-10 | RZLT | FAUCHET PHILIPPE | Dir | A - Grant | $0.00 | +9,000 | 34.5K | +35% | $0 |
| D | 2025-06-12 | 2025-06-10 | RZLT | Evans Daron | CFO | A - Grant | $0.00 | +26.0K | 263.9K | +11% | $0 |
| D | 2025-06-12 | 2025-06-10 | RZLT | Elam Nevan C | CEO, Dir | A - Grant | $0.00 | +68.0K | 292.1K | +30% | $0 |
| 2025-04-01 | 2025-03-31 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $2.92 | +6,758 | 84.0K | +9% | +$19.7K | |
| 2025-03-31 | 2025-03-27 | RZLT | Elam Nevan C | CEO, Dir | P - Purchase | $2.85 | +12.3K | 224.1K | +6% | +$35.1K | |
| 2025-03-28 | 2025-03-26 | RZLT | Evans Daron | CFO | P - Purchase | $2.89 | +10.0K | 237.9K | +4% | +$28.9K | |
| I | 2025-03-28 | 2025-03-26 | RZLT | Evans Daron | CFO | P - Purchase | $2.88 | +10.0K | 23.0K | +77% | +$28.8K |
| D | 2025-02-20 | 2025-02-16 | RZLT | Labrucherie Gil M | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2025-02-20 | 2025-02-18 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.70 | +10.0K | 77.3K | +15% | +$47.0K |
| D | 2025-02-20 | 2025-02-16 | RZLT | Hogenhuis Wladimir | Dir | A - Grant | $0.00 | +25.5K | 67.3K | +61% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | A - Grant | $0.00 | +77.0K | 131.4K | +142% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | Evans Daron | CFO | A - Grant | $0.00 | +77.0K | 227.9K | +51% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | FAUCHET PHILIPPE | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | Elam Nevan C | CEO, Dir | A - Grant | $0.00 | +204.0K | 211.8K | +2,610% | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | KREHER NERISSA | Dir | A - Grant | $0.00 | +25.5K | 25.5K | New | $0 |
| D | 2025-02-19 | 2025-02-16 | RZLT | Kim Young-Jin | Dir | A - Grant | $0.00 | +25.5K | 140.9K | +22% | $0 |
| DI | 2025-02-19 | 2024-06-25 | RZLT | Kim Young-Jin | Dir | P - Purchase | $4.00 | +1.25M | 7.19M | +21% | +$5.00M |
| 2024-12-18 | 2024-12-18 | RZLT | Evans Daron | CFO | P - Purchase | $4.29 | +10.0K | 150.9K | +7% | +$42.9K | |
| 2024-12-12 | 2024-12-12 | RZLT | Evans Daron | CFO | P - Purchase | $4.60 | +9,000 | 140.9K | +7% | +$41.4K | |
| 2024-12-10 | 2025-12-09 | RZLT | Evans Daron | CFO | P - Purchase | $5.04 | +10.5K | 131.9K | +9% | +$53.2K | |
| 2024-09-24 | 2024-09-24 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.70 | +4,259 | 41.8K | +11% | +$20.0K | |
| 2024-06-27 | 2024-06-25 | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.15 | +4,815 | 37.5K | +15% | +$20.0K | |
| MI | 2024-06-14 | 2024-06-14 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $3.92 | +3,300 | 1,376 | New | +$12.9K |
| M | 2024-06-14 | 2024-06-14 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $3.91 | +4,300 | 54.1K | +9% | +$16.8K |
| I | 2024-06-14 | 2024-06-14 | RZLT | Evans Daron | CFO | P - Purchase | $4.04 | +40.0K | 40.0K | New | +$161.6K |
| 2024-05-31 | 2024-05-29 | RZLT | Evans Daron | CFO | P - Purchase | $3.50 | +451 | 121.4K | +0.4% | +$1,578 | |
| MI | 2024-05-28 | 2024-05-23+ | RZLT | Evans Daron | CFO | P - Purchase | $3.22 | +3,000 | 10.1K | +43% | +$9,668 |
| M | 2024-05-28 | 2024-05-23 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $2.69 | +7,500 | 44.1K | +21% | +$20.2K |
| I | 2024-03-29 | 2024-03-28 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $2.55 | +500 | 1,076 | +87% | +$1,275 |
| M | 2024-03-19 | 2021-10-15+ | RZLT | HANDOK, INC. | Dir, 10% | P - Purchase | $4.33 | +3.93M | 2.78M | New | +$17.00M |
| I | 2024-03-19 | 2024-03-15 | RZLT | Evans Daron | CFO | P - Purchase | $1.69 | +20.0K | 20.0K | New | +$33.8K |
| I | 2024-03-18 | 2024-03-14 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.88 | +10.0K | 10.0K | New | +$18.8K |
| AI | 2024-03-18 | 2024-03-07 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.85 | +500 | 576 | +658% | +$925 |
| M | 2024-03-14 | 2022-07-22+ | RZLT | Kim Young-Jin | Dir | P - Purchase | $3.20 | +115.5K | 78.9K | New | +$369.7K |
| I | 2024-03-11 | 2024-03-07 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.85 | +500 | 500 | New | +$925 |
| 2024-03-08 | 2024-03-08 | RZLT | Evans Daron | CFO | P - Purchase | $1.93 | +50.0K | 120.9K | +71% | +$96.5K | |
| 2024-02-28 | 2024-02-26 | RZLT | Elam Nevan C | CEO, Dir | P - Purchase | $1.68 | +5,000 | 7,817 | +177% | +$8,400 | |
| M | 2024-02-27 | 2024-02-23+ | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.69 | +8,000 | 40.6K | +25% | +$13.5K |
| 2024-02-21 | 2024-02-16 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.31 | +7,000 | 34.6K | +25% | +$9,170 | |
| MI | 2024-02-20 | 2024-02-16 | RZLT | Evans Daron | CFO | P - Purchase | $1.37 | +9,000 | 4,500 | New | +$12.3K |
| 2024-02-20 | 2024-02-16 | RZLT | Evans Daron | CFO | P - Purchase | $1.30 | +41.9K | 70.9K | +144% | +$54.5K | |
| 2023-07-06 | 2023-07-03 | RZLT | ROBERTS BRIAN KENNETH | Chief Medical Off | P - Purchase | $1.90 | +5,000 | 27.6K | +22% | +$9,500 | |
| M | 2022-05-19 | 2022-05-17+ | RZLT | ROBERTS BRIAN KENNETH | SVP, Clinic Development | P - Purchase | $3.24 | +1,500 | 22.1K | +7% | +$4,867 |
| AI | 2022-05-09 | 2022-05-04 | RZLT | Labrucherie Gil M | Dir | P - Purchase | $3.80 | +52.6K | 53.6K | +5,593% | +$200.0K |
| 2022-05-06 | 2022-05-04 | RZLT | Labrucherie Gil M | Dir | P - Purchase | $3.80 | +52.6K | 52.6K | New | +$200.0K | |
| 2022-05-06 | 2022-05-04 | RZLT | ROBERTS BRIAN KENNETH | SVP, Clinic Development | P - Purchase | $3.80 | +21.1K | 21.1K | New | +$80.0K | |
| M | 2022-05-06 | 2021-10-15+ | RZLT | Hogenhuis Wladimir | Dir | P - Purchase | $4.44 | +32.7K | 7,693 | New | +$145.0K |
| D | 2021-07-28 | 2019-07-23 | RZLT | Genexine Inc. | 10% | P - Purchase | $0.29 | +34.48M | 91.30M | +61% | +$10.00M |
| D | 2021-07-28 | 2019-04-26 | RZLT | Genexine Inc. | 10% | C - Cnv Deriv | — | +56.82M | 56.82M | New | — |
Purchase Sale Sale after option exercise All abbreviations